Boston Trust Walden’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $51.8M | Sell |
572,928
-63,856
| -10% | -$5.86M | 0.43% | 86 |
|
|
2025
Q4 | $57.3M | Sell |
636,784
-23,344
| -4% | -$2.21M | 0.43% | 88 |
|
|
2025
Q3 | $65M | Sell |
660,128
-33,194
| -5% | -$3.29M | 0.48% | 77 |
|
|
2025
Q2 | $63.2M | Buy |
693,322
+215,249
| +45% | +$20.8M | 0.45% | 80 |
|
|
2025
Q1 | $54.1M | Buy |
+478,073
| New | +$51.1M | 0.4% | 99 |
|
|
2023
Q2 | – | Sell |
-5,695
| Closed | -$736K | – | 373 |
|
|
2023
Q1 | $736K | Hold |
5,695
| – | – | 0.01% | 291 |
|
|
2022
Q4 | $726K | Hold |
5,695
| – | – | 0.01% | 291 |
|
|
2022
Q3 | $595K | Buy |
5,695
+1,750
| +44% | +$192K | 0.01% | 291 |
|
|
2022
Q2 | $414K | Sell |
3,945
-4,910
| -55% | -$583K | ﹤0.01% | 313 |
|
|
2022
Q1 | $1.13M | Sell |
8,855
-40,425
| -82% | -$4.87M | 0.01% | 274 |
|
|
2021
Q4 | $6.08M | Sell |
49,280
-7,743
| -14% | -$1.01M | 0.05% | 237 |
|
|
2021
Q3 | $8.1M | Buy |
57,023
+12
| +0% | +$1.76K | 0.07% | 218 |
|
|
2021
Q2 | $8.9M | Buy |
57,011
+18,134
| +47% | +$2.94M | 0.08% | 218 |
|
|
2021
Q1 | $6.04M | Sell |
38,877
-212
| -0.5% | -$32.8K | 0.06% | 225 |
|
|
2020
Q4 | $5.85M | Sell |
39,089
-566
| -1% | -$79.9K | 0.06% | 230 |
|
|
2020
Q3 | $5.24M | Sell |
39,655
-10,650
| -21% | -$1.39M | 0.07% | 235 |
|
|
2020
Q2 | $5.83M | Sell |
50,305
-3,064
| -6% | -$353K | 0.08% | 220 |
|
|
2020
Q1 | $5.24M | Buy |
53,369
+309
| +0.6% | +$40.5K | 0.08% | 213 |
|
|
2019
Q4 | $7.71M | Buy |
53,060
+51
| +0.1% | +$7.04K | 0.09% | 215 |
|
|
2019
Q3 | $7.06M | Buy |
53,009
+3,430
| +7% | +$443K | 0.09% | 220 |
|
|
2019
Q2 | $5.67M | Buy |
49,579
+355
| +0.7% | +$41.6K | 0.07% | 223 |
|
|
2019
Q1 | $6.1M | Buy |
49,224
+4,661
| +10% | +$530K | 0.08% | 217 |
|
|
2018
Q4 | $4.49M | Buy |
44,563
+6,525
| +17% | +$734K | 0.07% | 227 |
|
|
2018
Q3 | $4.86M | Buy |
38,038
+3,474
| +10% | +$413K | 0.07% | 224 |
|
|
2018
Q2 | $3.74M | Buy |
34,564
+155
| +0.5% | +$16.9K | 0.05% | 239 |
|
|
2018
Q1 | $3.64M | Buy |
34,409
+669
| +2% | +$77.7K | 0.06% | 235 |
|
|
2017
Q4 | $3.95M | Buy |
33,740
+387
| +1% | +$43.8K | 0.06% | 235 |
|
|
2017
Q3 | $3.79M | Buy |
33,353
+11,015
| +49% | +$1.27M | 0.06% | 237 |
|
|
2017
Q2 | $2.78M | Buy |
+22,338
| New | +$2.65M | 0.04% | 254 |
|
|
2017
Q1 | – | Sell |
-22,775
| Closed | -$2.28M | – | 357 |
|
|
2016
Q4 | $2.28M | Buy |
22,775
+4,094
| +22% | +$439K | 0.04% | 257 |
|
|
2016
Q3 | $2.36M | Hold |
18,681
| – | – | 0.04% | 254 |
|
|
2016
Q2 | $2.18M | Hold |
18,681
| – | – | 0.04% | 262 |
|
|
2016
Q1 | $1.93M | Sell |
18,681
-31
| -0.2% | -$3K | 0.03% | 271 |
|
|
2015
Q4 | $1.86M | Buy |
+18,712
| New | +$1.83M | 0.03% | 262 |
|
Other funds holding ZBH
VCM
VPM
Boston Trust Walden's ZBH Position: Q1 2026 in Review
Boston Trust Walden reduced its Zimmer Biomet (ZBH) stake by 10% in Q1 2026, selling an estimated $5.86M and leaving 572,928 shares worth $51.8M. The position accounts for 0.43% of the portfolio, ranked #86.
Boston Trust Walden first reported a position in ZBH in Q4 2015 and has held it in 34 quarters since. The position peaked at $65M in Q3 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Boston Trust Walden held 572,928 shares of Zimmer Biomet worth $51.8M as of Q1 2026.
- Boston Trust Walden sold 63,856 Zimmer Biomet shares in Q1 2026, an estimated $5.86M.
- Zimmer Biomet made up 0.43% of Boston Trust Walden's portfolio in Q1 2026, its #86 holding.
- Boston Trust Walden first reported a position in Zimmer Biomet in Q4 2015 and has held it in 34 quarters since.
- Boston Trust Walden's Zimmer Biomet position peaked at $65M in Q3 2025.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Boston Trust Walden's 13F filing for Q1 2026, filed 24 Apr 2026.